- Conditions
- Hypertrophic Scar
- Interventions
- RXI-109
- Drug
- Lead sponsor
- RXi Pharmaceuticals, Corp.
- Industry
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2018
- U.S. locations
- 5
- States / cities
- Beverly Hills, California • Lake Worth, Florida • Chicago, Illinois + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–15
of 15
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Breast Hypertrophy, Abdominal Elastosis, Breast Reconstruction
- Interventions
- wound closure device (Steri-Strip™)
- Device
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Hypertrophic
- Interventions
- embrace device
- Device
- Lead sponsor
- Neodyne Biosciences, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 13
- States / cities
- Atherton, California • Bakersfield, California • Danville, California + 10 more
- Conditions
- Wound Heal, Scar, Scar, Hypertrophic, Keloid, Keloid Scar Following Surgery, Surgical Incision
- Interventions
- Preoperative silicone ointment, Preoperative placebo ointment
- Device · Other
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Reduction in Severity of Skin Scarring
- Interventions
- EXC 001 (currently called PF-06473871)
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 4
- States / cities
- Lake Worth, Florida • Chicago, Illinois • Eugene, Oregon + 1 more
- Conditions
- Surgical Incision, Surgery--Complications, Surgical Wound, Surgical Site Infection, Scar, Hypertrophic Scar
- Interventions
- Topical zinc oxide vs. petrolatum post-surgical scars
- Drug
- Lead sponsor
- Melissa Pugliano-Mauro
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Pittsburgh, PA, Pennsylvania
- Conditions
- Hypertrophic Scar
- Interventions
- OLX10010
- Drug
- Lead sponsor
- Olix Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 6
- States / cities
- Washington D.C., District of Columbia • Miami, Florida • Detroit, Michigan + 2 more
- Conditions
- Hypertrophic Scar
- Interventions
- RXI-109, Placebo
- Drug
- Lead sponsor
- RXi Pharmaceuticals, Corp.
- Industry
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2016
- U.S. locations
- 4
- States / cities
- Lake Worth, Florida • Chicago, Illinois • St Louis, Missouri + 1 more
- Conditions
- Scar Tissue, Hypertrophic Scar, Hypertrophic Scar of Upper Arm (Disorder), Hypertrophic Surgical Scar, Dry Needling
- Interventions
- True dry needling, Sham dry needling
- Other
- Lead sponsor
- Iran University of Medical Sciences
- Other
- Eligibility
- 20 Years to 60 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery
- Interventions
- PF-06473871
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 57 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 5
- States / cities
- Coral Gables, Florida • Miami, Florida • Atlanta, Georgia + 1 more
- Conditions
- Hypertrophic Scars
- Interventions
- Fraxel Repair - Fractional Laser treatment
- Device
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 50 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Reduction of Hypertrophic Skin Scarring
- Interventions
- PF-06473871
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 36
- States / cities
- Irvine, California • La Jolla, California • Walnut Creek, California + 20 more
- Conditions
- Scar, Surgical Scar, Cicatrix, Cicatrix, Hypertrophic, Keloid
- Interventions
- 532nm KTP, 595nm PDL
- Device
- Lead sponsor
- Cutera Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Reduction in Hypertrophic Skin Scarring
- Interventions
- EXC 001
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 12
- States / cities
- Pasadena, California • Whittier, California • Lake Worth, Florida + 7 more
- Conditions
- Hypertrophic
- Interventions
- embrace device
- Device
- Lead sponsor
- Neodyne Biosciences, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Palo Alto, California